Information Provided By: 
Fly News Breaks for June 8, 2016
ALGN
Jun 8, 2016 | 08:30 EDT
Roth Capital analyst Chris Lewis raised his price target for Align Technology to $88 from $80 given his reaffirmed confidence in the company's growth and profitability prospects. Lewis says he continues to view Align Technology as a "high-value" asset and sees the continued innovation of its Invisalign as a key driver of clinical confidence that should translate into increased ortho utilization over time. Roth Capital has a Buy rating on the shares.
News For ALGN From the Last 2 Days
ALGN
Apr 18, 2024 | 07:23 EDT
Stifel raised the firm's price target on Align Technology to $400 from $350 and keeps a Buy rating on the shares. Respondents to the firm's survey point to "solid" 2024 year-over-year case volume growth and while Invisalign's share is expected to step down "modestly" year-over-year, new product feedback is upbeat, says the firm, which adds that it has "an upside bias to our 2024 revenue estimate."
